Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment: An update

Gary J. Kelloff; Robert C. Bast; Donald S. Coffey; Anthony V. D'Amico; Robert S. Kerbel; John W. Park; Raymond W. Ruddon; Gordon J.S. Rustin; Richard L. Schilsky; Caroline C. Sigman; George F. Vande Woude

doi:10.1158/1078-0432.CCR-03-0783

Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment: An update

Gary J. Kelloff, Robert C. Bast, Donald S. Coffey, Anthony V. D'Amico, Robert S. Kerbel, John W. Park, Raymond W. Ruddon, Gordon J.S. Rustin, Richard L. Schilsky, Caroline C. Sigman, George F. Vande Woude

Research output: Contribution to journal › Review article › peer-review

48 Scopus citations

Original language	English (US)
Pages (from-to)	3881-3884
Number of pages	4
Journal	Clinical Cancer Research
Volume	10
Issue number	11
DOIs	https://doi.org/10.1158/1078-0432.CCR-03-0783
State	Published - Jun 1 2004
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-03-0783

Cite this

Kelloff, G. J., Bast, R. C., Coffey, D. S., D'Amico, A. V., Kerbel, R. S., Park, J. W., Ruddon, R. W., Rustin, G. J. S., Schilsky, R. L., Sigman, C. C., & Vande Woude, G. F. (2004). Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment: An update. Clinical Cancer Research, 10(11), 3881-3884. https://doi.org/10.1158/1078-0432.CCR-03-0783

Kelloff, GJ, Bast, RC, Coffey, DS, D'Amico, AV, Kerbel, RS, Park, JW, Ruddon, RW, Rustin, GJS, Schilsky, RL, Sigman, CC & Vande Woude, GF 2004, 'Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment: An update', Clinical Cancer Research, vol. 10, no. 11, pp. 3881-3884. https://doi.org/10.1158/1078-0432.CCR-03-0783

@article{4ab53da34b3d4dd3846f72c789d3cbfb,

title = "Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment: An update",

author = "Kelloff, {Gary J.} and Bast, {Robert C.} and Coffey, {Donald S.} and D'Amico, {Anthony V.} and Kerbel, {Robert S.} and Park, {John W.} and Ruddon, {Raymond W.} and Rustin, {Gordon J.S.} and Schilsky, {Richard L.} and Sigman, {Caroline C.} and {Vande Woude}, {George F.}",

year = "2004",

month = jun,

day = "1",

doi = "10.1158/1078-0432.CCR-03-0783",

language = "English (US)",

volume = "10",

pages = "3881--3884",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

TY - JOUR

T1 - Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment

T2 - An update

AU - Kelloff, Gary J.

AU - Bast, Robert C.

AU - Coffey, Donald S.

AU - D'Amico, Anthony V.

AU - Kerbel, Robert S.

AU - Park, John W.

AU - Ruddon, Raymond W.

AU - Rustin, Gordon J.S.

AU - Schilsky, Richard L.

AU - Sigman, Caroline C.

AU - Vande Woude, George F.

PY - 2004/6/1

Y1 - 2004/6/1

UR - http://www.scopus.com/inward/record.url?scp=2542637301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542637301&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-03-0783

DO - 10.1158/1078-0432.CCR-03-0783

M3 - Review article

C2 - 15173097

AN - SCOPUS:2542637301

SN - 1078-0432

VL - 10

SP - 3881

EP - 3884

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 11

ER -

Biomarkers, surrogate end points, and the accelleration of drug development for cancer prevention and treatment: An update

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this